{"id":"W2319342693","doi":"10.1136/annrheumdis-2013-eular.308","title":"OP0103 Efficacy of Brodalumab, an Anti-IL-17R Antibody, in Subjects with Psoriatic Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Clinical endpoint; Psoriasis; Adverse effect; Rheumatology; Randomized controlled trial; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000587969,0.0003875014,0.001260428,0.0001958761,0.0002543872,0.0006405046,0.000303818,0.0006197515,0.0021761],"category_scores_gemma":[0.0005541006,0.0002495985,0.0008292324,0.0001522699,0.0002457445,0.0003190992,0.0001404414,0.001306499,0.0004329106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003510847,"about_ca_system_score_gemma":0.0004569157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001849691,"about_ca_topic_score_gemma":0.00423295,"domain_scores_codex":[0.9997528,0.00007441259,0.00002019574,0.00003485846,0.00003975603,0.00007792692],"domain_scores_gemma":[0.9997149,0.00007897925,0.00004954779,0.00001965855,0.00002730384,0.0001095068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5541325,0.01449808,0.04491759,0.001638562,0.002799911,0.0005897541,0.0002762993,0.001046461,0.07028795,0.0002829795,0.004004668,0.3055252],"study_design_scores_gemma":[0.1654602,0.2749183,0.5254649,0.0003710842,0.005902652,0.001481247,0.0004836925,0.003167627,0.01412909,0.0004566053,0.008042273,0.0001223894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910365,0.005932602,0.00008525133,0.0002962195,0.0001287225,0.00005792291,0.0002897521,0.00004507033,0.002127824],"genre_scores_gemma":[0.9968129,0.001216402,0.0001182423,0.0002529542,0.00006764057,0.0000277697,0.0003131184,0.000005020362,0.00118599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0021761,"threshold_uncertainty_score":0.007279813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02035229992375236,"score_gpt":0.2687368759988796,"score_spread":0.2483845760751273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}